Letter regarding "Minimal change disease relapse following SARS-CoV-2 mRNA vaccine"

Kidney Int. 2021 Aug;100(2):458-459. doi: 10.1016/j.kint.2021.05.006. Epub 2021 May 27.

Authors

Nora Schwotzer¹, Sébastien Kissling², Fadi Fakhouri²

Affiliations

¹ Service of Nephrology and Hypertension, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland. Electronic address: [email protected].
² Service of Nephrology and Hypertension, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19 Vaccines
COVID-19*
Humans
Nephrosis, Lipoid*
RNA, Messenger
Recurrence
SARS-CoV-2

Substances

COVID-19 Vaccines
RNA, Messenger